Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells

Abstract

A series of nine tetrahydroacridine derivatives with iodobenzoic moiety were synthesized and evaluated for their cytotoxic activity against cancer cell lines-A549 (human lung adenocarcinoma), HT-29 (human colorectal adenocarcinoma) and somatic cell line-EA.hy926 (human umbilical vein cell line). All compounds displayed high cytotoxicity activity against A549 (IC 50 59.12-14.87 µM) and HT-29 (IC 50 17.32-5.90 µM) cell lines, higher than control agents-etoposide and 5-fluorouracil. Structure-activity relationship showed that the position of iodine in the substituent in the para position and longer linker most strongly enhanced the cytotoxic effect. Among derivatives, 1i turned out to be the most cytotoxic and displayed IC 50 values of 14.87 µM against A549 and 5.90 µM against HT-29 cell lines. In hyaluronidase inhibition assay, all compounds presented anti-inflammatory activity, however, slightly lower than reference compound. ADMET prediction showed that almost all compounds had good pharmacokinetic profiles. 1b, 1c and 1f compounds turned out to act against chemoresistance in cisplatin-resistant 253J B-V cells. Compounds intercalated into DNA and inhibited cell cycle in G0/G1 phase-the strongest inhibition was observed for 1i in A549 and 1c in HT-29. Among compounds, the highest apoptotic effect in both cell lines was observed after treatment with 1i. Compounds caused DNA damage and H2AX phosphorylation, which was detected in A549 and HT-29 cells. All research confirmed anticancer properties of novel tetrahydroacridine derivatives and explained a few pathways of their mechanism of cytotoxic action.

Cytotoxic Activity against A549 Human Lung Cancer Cells and ADMET Analysis of New Pyrazole Derivatives

“…The viability and cell cycle analysis results were presented as mean ± standard deviation. All assays were performed in triplicate, and the results were obtained in three independent experiments [35].…”

Characterization of Metal-Bound Benzimidazole Derivatives, Effects on Tumor Cells of Lung Cancer

“…The standard analytical wavelength for this complex is 570 nm in a mixture of dimethylsulfoxide (DMSO) (Serva) and Sorensen’s glycine buffer. The experiments were done in triplicate [ 42 ]. The concentration of analyzed compounds was used to determine IC 50 values.…”

Characterization of lncRNA-Associated ceRNA Network to Reveal Potential Prognostic Biomarkers in Lung Adenocarcinoma

“…It should be noted that the cell cycle is a tightly regulated process, which is frequently aberrant in lung cancer (Shcherba et al, 2014). By inhibiting the unrestricted cell division and growth of lung cancer cells, cell cycle-related genes have emerged as new targets for the treatment of lung cancer (Girek et al, 2019).…”

“…Studies reported that IGF2BP1 has been traditionally regarded as an oncogene and potential therapeutic target for cancers (Huang et al, 2018). It plays essential roles in embryogenesis and carcinogenesis, regulating the expression of some essential mRNA targets required for the control of tumor cell proliferation, growth, and invasion, and associating with a poor overall survival and metastasis in various types of human cancers (Gong et al, 2016). However, there is no public report on miR1293 and LINC01740 according to a PubMed search.…”